VEGF-mediated cross-talk within the neonatal murine thymus.

Although the mechanisms of cross-talk that regulate the hematopoietic and epithelial compartments of the thymus are well established, the interactions of these compartments with the thymic endothelium have been largely ignored. Current understanding of the thymic vasculature is based on studies of adult thymus. We show that the neonatal period represents a unique phase of thymic growth and differentiation, marked by endothelium that is organized as primitive, dense networks of capillaries dependent on vascular endothelial growth factor (VEGF). VEGF dependence in neonates is mediated by significantly higher levels of both VEGF production and endothelial VEGF receptor 2 (VEGF-R2) expression than in the adult thymus. VEGF is expressed locally in the neonatal thymus by immature, CD4(-)CD8(-) "double negative" (DN) thymocytes and thymic epithelium. Relative to adult thymus, the neonatal thymus has greater thymocyte proliferation, and a predominance of immature thymocytes and cortical thymic epithelial cells (cTECs). Inhibition of VEGF signaling during the neonatal period results in rapid loss of the dense capillaries in the thymus and a marked reduction in the number of thymocytes. These data demonstrate that, during the early postnatal period, VEGF mediates cross-talk between the thymocyte and endothelial compartments of the thymus.

[1]  D. Carbone,et al.  Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. , 2007, Blood.

[2]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[3]  S. Parnell,et al.  Establishment and functioning of intrathymic microenvironments , 2006, Immunological reviews.

[4]  Betty Y. Y. Tam,et al.  VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. , 2006, American journal of physiology. Heart and circulatory physiology.

[5]  D. McDonald,et al.  Effect of inhibition of vascular endothelial growth factor signaling on distribution of extravasated antibodies in tumors. , 2006, Cancer research.

[6]  P. Carmeliet,et al.  Gene targeting of VEGF-A in thymus epithelium disrupts thymus blood vessel architecture. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Yancopoulos,et al.  Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period , 2005, Development.

[8]  Maureen A Su,et al.  Aire: an update. , 2004, Current opinion in immunology.

[9]  Gavin Thurston,et al.  Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. , 2004, The American journal of pathology.

[10]  K. Tang,et al.  Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. , 2004, Physiological genomics.

[11]  B. Olsen,et al.  VEGFA is necessary for chondrocyte survival during bone development , 2004, Development.

[12]  Gavin Thurston,et al.  Age-Related Changes in Vascular Endothelial Growth Factor Dependency and Angiopoietin-1–Induced Plasticity of Adult Blood Vessels , 2004, Circulation research.

[13]  I. Cohen,et al.  Angiogenesis-Inflammation Cross-Talk: Vascular Endothelial Growth Factor Is Secreted by Activated T Cells and Induces Th1 Polarization , 2004, The Journal of Immunology.

[14]  H. Hammes,et al.  Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor , 2004, Thrombosis and Haemostasis.

[15]  D. Melton,et al.  Role of VEGF-A in Vascularization of Pancreatic Islets , 2003, Current Biology.

[16]  D. Carbone,et al.  VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. , 2003, Blood.

[17]  G. Yancopoulos,et al.  VEGF-Trap: A VEGF blocker with potent antitumor effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Balling,et al.  Thymopoiesis requires Pax9 function in thymic epithelial cells , 2002, European journal of immunology.

[19]  I. Goldschneider,et al.  Functional demonstration of intrathymic binding sites and microvascular gates for prothymocytes in irradiated mice. , 2002, International immunology.

[20]  D. Gray,et al.  Analysis of thymic stromal cell populations using flow cytometry. , 2002, Journal of immunological methods.

[21]  H. Petrie,et al.  Cell migration and the anatomic control of thymocyte precursor differentiation. , 2000, Seminars in immunology.

[22]  S. Anderson,et al.  Thymic vasculature: organizer of the medullary epithelial compartment? , 2000, International immunology.

[23]  G. Holländer,et al.  Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. , 2000, Development.

[24]  R. Kiessling,et al.  Tumor-induced immune dysfunction , 1999, Cancer Immunology, Immunotherapy.

[25]  M Aguet,et al.  VEGF is required for growth and survival in neonatal mice. , 1999, Development.

[26]  D. McDonald,et al.  Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. , 1996, The American journal of physiology.

[27]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[28]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[29]  G. Matsuzaki,et al.  CD3−CD8+ intestinal intraepithelial lymphocytes (IEL) and the extrathymic development of IEL , 1994, European journal of immunology.

[30]  A. Zlotnik,et al.  Control points in early T-cell development. , 1993, Immunology today.

[31]  A. Zlotnik,et al.  A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. , 1993, Journal of immunology.

[32]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[33]  T. Taniguchi,et al.  The IL-2 IL-2 receptor system: A current overview , 1993, Cell.

[34]  S. Tonegawa,et al.  Localization of gamma/delta T cells to the intestinal epithelium is independent of normal microbial colonization , 1990, The Journal of experimental medicine.

[35]  E. Raviola,et al.  EVIDENCE FOR A BLOOD-THYMUS BARRIER USING ELECTRON-OPAQUE TRACERS , 1972, The Journal of experimental medicine.

[36]  D. Gray,et al.  Unbiased analysis, enrichment and purification of thymic stromal cells. , 2008, Journal of immunological methods.

[37]  M. Arcangeli,et al.  The thymus exports long-lived fully committed T cell precursors that can colonize primary lymphoid organs , 2006, Nature Immunology.

[38]  A. Hayday.  Orchestrated leak provokes a thymus reassessment , 2006, Nature Immunology.

[39]  N. Ferrara,et al.  The role of VEGF in normal and neoplastic hematopoiesis , 2002, Journal of Molecular Medicine.

[40]  Gregory D. Sempowski,et al.  The human thymus during aging , 2000, Immunologic research.

[41]  H. Kawamoto,et al.  Developing thymocytes organize thymic microenvironments. , 2000, Current topics in microbiology and immunology.

[42]  G. Steinmann.  Changes in the human thymus during aging. , 1986, Current topics in pathology. Ergebnisse der Pathologie.